The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Circadian and sleep disorders in Parkinson's disease
Open accessAbstract
Impaired sleep and alertness, initially recognized by James Parkinson in his famous monograph "An Essay on the Shaking Palsy" in 1817, is one of the most common and disabling nonmotor symptoms of Parkinson's disease (PD). It is only recently, however, that sleep disturbances in PD have received the attention of medical and research community. Dopamine, the major neurotransmitter implicated in the pathogenesis of PD, plays a pivotal role in the regulation of sleep and circadian homeostasis. Sleep dysfunction affects up to 90% of patients with PD, and may precede the onset of the disease by decades. Sleep dysfunction in PD may be categorized into disturbances of overnight sleep and daytime alertness. Etiology of impaired sleep and alertness in PD is multifactorial. Co-existent primary sleep disorders, medication side effects, overnight re-emergence of motor symptoms, and primary neurodegeneration itself, are main causes of sleep disruption and excessive daytime sleepiness among patients with PD. Increasing body of evidence suggests that the circadian system becomes dysregulated in PD, which may lead to poor sleep and alertness. Treatment options are limited and frequently associated with unwanted side effects. Further studies that will examine pathophysiology of sleep dysfunction in PD, and focus on novel treatment approaches are therefore very much needed. In this article we review the role of dopamine in regulation of sleep and alertness and discuss main sleep and circadian disturbances associated with PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Degeneration of these regions likely begins prior to degeneration of the substantia nigra (Braak et al. 2003), and accounts for many of the non-motor features seen in PD.”
BackgroundRestless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900
Dibner, C., Schibler, U., & Albrecht, U. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135821 · Cited by 2,421
Rascol, O., Brooks, D. J., Korczyn, A. D., De Deyn, P. P., Clarke, C. E., & Lang, A. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005183422004 · Cited by 1,539
Sleep and circadian rhythm disruption in psychiatric and neurodegenerative disease
Wulff, K., Gatti, S., Wettstein, J. G., & Foster, R. G. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2868 · Cited by 1,055
Schenck, C. H., & Mahowald, M. W. (2002) · SLEEP · doi:10.1093/sleep/25.2.120 · Cited by 770
MRI measurement of brain iron in patients with restless legs syndrome
Allen, R. P., Barker, P. B., Wehrl, F., Song, H. K., & Earley, C. J. (2001) · Neurology · doi:10.1212/wnl.56.2.263 · Cited by 570
Hypocretin (orexin) cell loss in Parkinson's disease
Thannickal, T. C., Lai, Y.-Y., & Siegel, J. M. (2007) · Brain · doi:10.1093/brain/awm097 · Cited by 566
Regulation of dopaminergic transmission and cocaine reward by the Clock gene
McClung, C. A., Sidiropoulou, K., Vitaterna, M., Takahashi, J. S., White, F. J., Cooper, D. C., & Nestler, E. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503584102 · Cited by 493 · cited 1×
“An increased dopaminergic function in the clock mutant mouse might be the basis for an altered cocaine-reward behavior (McClung et al. 2005).”
BackgroundHypocretin (orexin) loss in Parkinson's disease
Fronczek, R., Overeem, S., Lee, S. Y. Y., Hegeman, I. M., van Pelt, J., van Duinen, S. G., Lammers, G. J., & Swaab, D. F. (2007) · Brain · doi:10.1093/brain/awm090 · Cited by 463
The Nighttime Problems of Parkinsonʼs Disease
Lees, A. J., Blackburn, N. A., & Campbell, V. L. (1988) · Clinical Neuropharmacology · doi:10.1097/00002826-198812000-00004 · Cited by 444
Association of sleep-wake habits in older people with changes in output of circadian pacemaker
Czeisler, C. A., Dumont, M., Duffy, J. F., Steinberg, J. D., Richardson, G. S., Brown, E. N., Sánchez, R., Ríos, C. D., & Ronda, J. M. (1992) · The Lancet · doi:10.1016/0140-6736(92)92817-y · Cited by 437
Neuroendocrine rhythms and sleep in aging men
van Coevorden, A., Mockel, J., Laurent, E., Kerkhofs, M., L'Hermite-Baleriaux, M., Decoster, C., Neve, P., & Van Cauter, E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.4.e651 · Cited by 336 · cited 1×
“…been associated with reduced amplitude of some circadian rhythms, and increased inter-daily variability (decreased stability) of a rhythm, such as the rest-activity cycle (Czeisler et al. 1992, Duffy et al. 2002, Hofman 2000, Touitou and Haus 2000, Turek et al. 1995, van Coevorden et al. 1991).”
BackgroundHood, S., Cassidy, P., Cossette, M.-P., Weigl, Y., Verwey, M., Robinson, B., Stewart, J., & Amir, S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2128-10.2010 · Cited by 246
Sleepiness in Parkinson's disease: A controlled study
Brodsky, M. A., Godbold, J., Roth, T., & Olanow, C. W. (2003) · Movement Disorders · doi:10.1002/mds.10429 · Cited by 169
Sleep Disruption in Parkinson's Disease: Assessment by Continuous Activity Monitoring
van Hilten, B. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540210094018 · Cited by 166 · cited 2×
“Increased levels of physical activity and shorter periods of immobility during the night, result in an almost flat diurnal pattern of motor activity in PD (van Hilten et al. 1994, van Hilten et al. 1993).”
BackgroundBright light therapy in Parkinson's disease: a pilot study
Paus, S., Schmitz‐Hübsch, T., Wüllner, U., Vogel, A., Klockgether, T., & Abele, M. (2007) · Movement Disorders · doi:10.1002/mds.21542 · Cited by 162
Sleipness, E. P., Sorg, B. A., & Jansen, H. T. (2007) · Brain Research · doi:10.1016/j.brainres.2006.10.063 · Cited by 160 · cited 1×
“…is at least partially responsible for normal day/night differences in DAT and TH protein expression in the nucleus accumbens, medial prefrontal cortex (mPFC), and caudate (Sleipness et al. 2007), as well as for the day/night variation in cocaine-seeking behavior in rats (Sleipness et al. 2007).”
BackgroundHeart rate variability in patients with untreated Parkinson's disease
Kallio, M., Haapaniemi, T., Turkka, J., Suominen, K., Tolonen, U., Sotaniemi, K., Heikkilä, V. ‐., & Myllylä, V. (2000) · European Journal of Neurology · doi:10.1046/j.1468-1331.2000.00127.x · Cited by 115 · cited 1×
“…blood pressure monitoring in patients with PD demonstrates reversal of circadian rhythm of blood pressure, increased diurnal blood pressure variability, postprandial hypotension, and a high nocturnal blood pressure (Ejaz et al. 2006, Kallio et al. 2000, Plaschke et al. 1998, Senard et al. 1992).”
BackgroundSilva, E. J., Wang, W., Ronda, J. M., Wyatt, J. K., & Duffy, J. F. (2010) · Sleep · doi:10.1093/sleep/33.4.481 · Cited by 114
Diurnal effects of motor activity and fatigue in Parkinson's disease.
van Hilten, J. J., Hoogland, G., van der Velde, E. A., Middelkoop, H. A., Kerkhof, G. A., & Roos, R. A. (1993) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.8.874 · Cited by 105
Illuminating rationale and uses for light therapy
Shirani, A., & St. Louis, E. K. (2009) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27445 · Cited by 97
Porter, B., Macfarlane, R., & Walker, R. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2007.01998.x · Cited by 92
Diurnal motor variations to repeated doses of levodopa in Parkinson's disease
Bonuccelli, U., Del Dotto, P., Lucetti, C., Petrozzi, L., Bernardini, S., Gambaccini, G., Rossi, G., & Piccini, P. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200001000-00006 · Cited by 79
Gravotta, L., Gavrila, A. M., Hood, S., & Amir, S. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9520-8 · Cited by 74
Nutt, J. G., Woodward, W. R., Carter, J. H., & Trotman, T. L. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.4.481 · Cited by 49
Circadian rhythms in catecholamine metabolites and cyclic nucleotide production
Kafka, M. S., Benedito, M. A., Roth, R. H., Steele, L. K., Wolfe, W. W., & Catravas, G. N. (1986) · Chronobiology International · doi:10.3109/07420528609066354 · Cited by 45
Effect of dopaminergic substances on sleep/wakefulness in saline – and MPTP-treated mice
LALOUX, C., DERAMBURE, P., HOUDAYER, E., JACQUESSON, J., BORDET, R., DESTÉE, A., & MONACA, C. (2008) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00625.x · Cited by 40
Effects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study
Boulamery, A., Simon, N., Vidal, J., & Bruguerolle, B. (2010) · Chronobiology International · doi:10.3109/07420521003664213 · Cited by 38 · cited 2×
“…timing system comes from neurochemical lesions with 6-hydroxydopamine injection, which disrupt normal circadian patterns of behavior and expression of Per2 (another core clock gene)(Gravotta et al. 2011); these alterations can be partially reversed by L-DOPA administration (Boulamery et al. 2010).”
BackgroundPlacidi, F., Izzi, F., Romigi, A., Stanzione, P., Marciani, M. G., Brusa, L., Sperli, F., Galati, S., Pasqualetti, P., & Pierantozzi, M. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0836-4 · Cited by 21 · cited 1×
“…al. 2003, Devos et al. 2003, Ejaz et al. 2006, Mihci et al. 2006, Pathak and Senard 2006, Pursiainen et al. 2002), sleep-wake cycles (Comella 2007, Placidi et al. 2008, Porter et al. 2008, van Hilten et al. 1993, Verbaan et al. 2008), visual performance (Struck et al. 1990), as well as…”
Background
Cited by
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
'The clocks that time us'—circadian rhythms in neurodegenerative disorders
Videnovic, A., Lazar, A. S., Barker, R. A., & Overeem, S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.206 · Cited by 373
Self-citationStefani, A., & Högl, B. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0448-y · Cited by 274
Dopamine: A Modulator of Circadian Rhythms in the Central Nervous System
Korshunov, K. S., Blakemore, L. J., & Trombley, P. Q. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00091 · Cited by 173
Diet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
“Patients with PD have poor sleep and reversal of sleep/wake cycles that can cause disruption of circadian rhythms (129, 130) and both disrupted sleep and circadian disruption can cause dysbiotic microbiota in both humans and rodents (131, 132).”
Background
Metadata
- Authors
- Videnovic, A., & Golombek, D.
- Venue
- Experimental Neurology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 243
- Pages
- 45-56
- ISSN
- 0014-4886 (ISSN-L)
- OpenAlex
- W1994677586
- Cited by
- 245
- References
- 30
- FWCI
- 7.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.